Plenary Session
Session 1 – Practical implementation of GDMT in the clinical setting
Chairs – Vijay Chopra and Tarek Bekfani
-
Physicians perceptions towards implementing GDMT in HF – Gianluigi Savarese
-
Contemporary GDMT sequencing and titration – Jasper Brugts
-
Dietary sodium and fluid intake in HF – Justin Ezekowitz
-
Panel discussion
Meet the Expert
SGLT2 inhibitors in real life: everything the clinician needs to know
Andrew Coats and Patricia Campbell
Supported by an unrestricted educational grant from Boehringer Ingelheim
Plenary Session
Session 2 – SGLT2s in clinical practice
Chairs – John Atherton and Tarek Bekfani
-
SGLT2 in post MI HF – Javed Butler
-
SGLT2 inhibitors early initiation – Clara Inés Saldarriaga
-
SGLT2 and cardiorenal protection – Faiez Zannad
-
Panel discussion
Special session 1 – Cardiac rhythm management devices: cornerstones of comprehensive, patient-centred HF care The-DIRECT-HF initiative
Chairs – Javed Butler and Shelley Zieroth
-
Welcome from Medtronic – Hela Ben Hamouda
-
Introduction to the DIRECT HF educational programme – Javed Butler
-
Cardiac rhythm management devices: cornerstones of comprehensive, patient-centred HF care – Shelley Zieroth and Wilfried Mullens
-
Prevention of sudden cardiac death: relevance in contemporary HF care – Christophe Leclercq, Gianluigi Savarese and Biykem Bozkurt
-
ICD therapy in HF: the patient’s perspective
-
Panel discussion – Biykem Bozkurt, Javed Butler, Loreena Hill, Giuseppe Rosano, Gianluigi Savarese and Shelley Zieroth
-
Conclusion – Shelley Zieroth
The DIRECT HF educational programme is supported by Medtronic
Meet the Expert
GDMT implementation in HF: how to tackle clinical inertia?
-
Current state of GDMT implementation in HF: clinical and organisational barriers
-
Tackling clinical inertia to improve GDMT use and improve patient outcomes
Giuseppe Rosano and Stephen Greene
Supported by unrestricted educational grant funding from AstraZeneca
Plenary Session
Session 3 – Obesity and weight management in HF
Chairs – Stefan Anker and Petar Seferovic
-
Obesity and HF: epidemiology and mechanisms – Naveed Sattar
-
Weight management in HFpEF – Shelley Zieroth
-
Overview of current therapeutic agents – Shahzeb Khan
-
The role of GLP-1RA and HF – Peter Rossing
-
Panel discussion
Special session 2 – Face to face with cardiac amyloidosis
Thibaud Damy and Lawrence Sherman
Plenary Session
Session 4 – Managing cardiomyopathy in HF
Chairs – Arnt Kristen and Carsten Tschöpe
Epidemiology and clinical features – Arnt Kristen
Differential diagnosis – Michelle Kittleson
Management of cardiac amyloidosis – Marianna Fontana
New approaches in the management of HCM – Arnt Kristen
Panel discussion
Meet the Expert
Management of transthyretin amyloid cardiomyopathy (ATTRCM): optimising patient pathways
Marianna Fontana and Arnt Kristen
Supported by unrestricted educational grant funding from AstraZeneca
Plenary Session
Session 5 – Cardiac rhythm in HF
Chairs – Andrea Russo and Fausto Pinto
-
The role of CRM devices in HF – Klaus Witte
-
Prevention of sudden arrhythmic death in HFrEF – Carsten Israel
-
CRT in HFrEF for whom and when – William Abraham
-
A modular communicative leadless pacing-defibrillator system – Reinoud Knops
-
Panel discussion
Meet the Expert
SGLT2 inhibitors in real life: everything the clinician needs to know
Andrew Coats and Patricia Campbell
Supported by an unrestricted educational grant from Boehringer Ingelheim
Plenary Session
Session 6 – Devices in HF; time to reassess their place?
Chairs – Ileana Piña and Stefan Anker
-
Neuromodulation therapy for HFrEF – David Duncker
-
CCM: benefits of early implementation – Marat Fudim
-
The role of MCS in acute HF – Dirk Westermann
-
Sleep apnea – William Abraham
-
Panel discussion
Meet the Expert
IV iron in clinical practice: experts’ perspectives
Patricia Campbell and Paul Kalra
Supported by an unrestricted educational grant from Pharmacosmos
Plenary Session
Session 7 – Enabling GDMT in HF
Chairs – David Sim and Alicia Chan
-
The role of potassium binders – Gianluigi Savarese
-
Non-steroidal MRAs – Gerasimos Filippatos
-
The role of SGLT2i in preventing hyperkalemia – Joao Ferreira
-
Panel discussion
Meet the Expert
Hyperkalemia in HF: clinical impact and long-term management
Chair – Shelley Zieroth
Hyperkalemia in HF: impact on GDMT use and outcomes – Gianluigi Savarese
Long-term potassium management in HF: practical guidance – Shahzeb Khan
Supported by unrestricted educational grant funding from AstraZeneca
Plenary Session
Session 8 – Iron deficiency: the totality of evidence
Chairs – Mitja Lainscak and Giuseppe Rosano
-
Iron deficiency in HFrEF – Ewa Jankowska
-
Latest data on ferric derisomaltose – Paul Kalra
-
How to keep to the diagnosis simple? – John Cleland
-
Panel discussion
Symposium
SGLT2 inhibitors in heart failure: updates on prevention and treatment
Stefan Anker, Biykem Bozkurt, Michael Böhm and Clara Ines Saldarriaga
Supported by an unrestricted educational grant from Boehringer Ingelheim
Plenary Session
Session 9 – Managing HFpEF in 2024
Chairs – Harriette Van Spall and Biykem Bozkurt
-
The role of non-steroidal MRAs – Muthiah Vaduganathan
-
The effect of iron on patients with HFpEF – Stefan Anker
-
The potential role of interleukin-6 (IL-6) antibodies in HFpEF – Mark Petrie
-
Panel discussion
Meet the Expert
Non-steroidal MRAs: evolving role in heart failure
Gerasimos Filippatos and Muthiah Vaduganathan
Supported by an unrestricted educational grant from Bayer
Plenary Session
Session 10 – Valvular heart disease
Chairs – Piotr Ponikowski and Ahmed Bennis
-
Drugs and interventions in HF – Marianna Adamo
-
Targeting FMR – Stefan Anker
-
Management of TR in HF – Karl Kresoja
-
Panel discussion
Plenary Session
Session 11 – Remote monitoring and team approaches in the management of HF
Chairs – Maria Rosa Costanzo and JoAnn Lindenfeld
-
Latest experience with haemodynamic monitoring – JoAnn Lindenfeld
-
Reducing HF hospitalisation by disease management programme – Nicolas Girerd
-
Reveal Linq – Javed Butler
-
Panel discussion
Meet the Expert
Replay: Management of transthyretin amyloid cardiomyopathy (ATTRCM): optimising patient pathways
Marianna Fontana and Arnt Kristen
Supported by unrestricted educational grant funding from AstraZeneca
Prof William Abraham
The Ohio State University, Ohio, US
Dr Marianna Adamo
Civil Hospital of Brescia, Brescia, IT
Prof Stefan Anker
Charité Campus Virchow-Klinikum, Berlin, DE
Prof John Atherton
Royal Brisbane and Women’s Hospital, Brisbane, AU
Dr Tarek Bekfani
University hospital Magdeburg A.o.R., Magdeburg, DE
Prof Ahmed Bennis
Ibn Rochd University Hospital, Casablanca, MA
Prof Michael Böhm
Saarland University Hospital, Homburg, DE
Prof Biykem Bozkurt
Baylor College of Medicine, Texas, US
Prof Jasper Brugts
Erasmus University Medical Centre, Rotterdam, NL
Prof Javed Butler
Baylor Scott and White Research Institute, Texas, US
Dr Patricia Campbell
Craigavon Area hospital, Portadown, UK
Dr Alicia Chan
Western HeartCare, Henley Beach, AU
Prof Vijay Chopra
Max Super Speciality Hospital, New Delhi, IN
Prof John Cleland
University of Glasgow, Glasgow, UK
Prof Andrew Coats
Heart Research Institute, NSW, AU
Prof Thibaud Damy
University Hospital Henri Mondor, Creteil, FR
Prof David Duncker
Hannover Heart Rhythm Center, Hannover, DE
Prof Justin Ezekowitz
University of Alberta, Edmonton, CA
Dr Joao Ferreira
University of Porto, Porto, PT
Prof Gerasimos Filippatos
National and Kapodistrian University of Athens, Athens, GR
Prof Marianna Fontana
University College London, London, UK
Dr Marat Fudim
Duke University, Durham, US
Dr Nicolas Girerd
University Hospital of Nancy, Nancy, FR
Dr Stephen Greene
Duke Clinical Research Institute, North Carolina, US
Prof Clara Inés Saldarriaga
University of Antioquia, Medellín, CO
Dr Carsten Israel
Bethel-Clinic, Bielefeld, DE
Prof Ewa Jankowska
Wrocław Medical University, Wrocław, PL
Shahzeb Kahn
Baylor Scott & White Health, Texas, US
Prof Paul Kalra
Portsmouth Hospitals NHS Trust, Portsmouth, UK
Dr Michelle Kittleson
Cedars-Sinai Heart Institute, California, US
Dr Reinoud Knops
Amsterdam University Medical Center, NL
Dr Karl Kresoja
Heart Center of Leipzig, Leipzig, DE
Prof Arnt Kristen
University of Heidelberg, Heidelberg, DE
Dr Mitja Lainscak
General Hospital Murska Sobota, Murska Sobota, SI
Dr JoAnn Lindenfeld
Vanderbilt University Medical Center,Tennessee, US
Dr Milton Packer
Baylor University Medical Center, Texas, US
Prof Mark Petrie
University of Glasgow, Glasgow, UK
Dr Ileana Piña
Thomas Jefferson University, Philadelphia, US
Prof Fausto Pinto
Santa Maria Hospital - CHULN, Lisbon, PT
Prof Piotr Ponikowski
Wroclaw Medical University, Wroclaw, PL
Dr Maria Rosa Costanzo
Midwest Cardiovascular Institute, Illinois, US
Prof Giuseppe Rosano
St Georges Medical School, London, UK
Prof Peter Rossing
University of Copenhagen, Copenhagen, DK
Dr Andrea Russo
Cooper Medical School of Rowan University, New Jersey, US
Prof Naveed Sattar
University of Glasgow, Glasgow, UK
Prof Gianluigi Savarese
Karolinska Institute, Stockholm, SE
Prof Petar Seferovic
University Clinical Center of Serbia, Belgrade, RS
Lawrence Sherman
Meducate Global
Dr David Sim
National Heart Centre Singapore, SG
Prof Carsten Tschöpe
German Heart Centre Berlin, Berlin, DE
Prof Muthiah Vaduganathan
Brigham and Women's Hospital, Massachusetts, US
Prof Harriette Van Spall
McMaster University, Hamilton, CA
Prof Dirk Westermann
University Heart Center Freiburg-Bad Krozingen, Freiburg, DE
Prof Klaus Witte
University of Leeds, Leeds, UK
Prof Faiez Zannad
University of Lorraine, Vandoeuvre-Les-Nancy, FR
Prof Shelley Zieroth
St. Boniface Hospital, Winnipeg, CA
